» Articles » PMID: 15340066

Inactivation of Stat5 in Mouse Mammary Epithelium During Pregnancy Reveals Distinct Functions in Cell Proliferation, Survival, and Differentiation

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Sep 2
PMID 15340066
Citations 287
Authors
Affiliations
Soon will be listed here.
Abstract

This study explored the functions of the signal transducers and activators of transcription 5a and 5b (referred to as Stat5 here) during different stages of mouse mammary gland development by using conditional gene inactivation. Mammary gland morphogenesis includes cell specification, proliferation and differentiation during pregnancy, cell survival and maintenance of differentiation throughout lactation, and cell death during involution. Stat5 is activated by prolactin, and its presence is mandatory for the proliferation and differentiation of mammary epithelium during pregnancy. To address the question of whether Stat5 is also necessary for the maintenance and survival of the differentiated epithelium, the two genes were deleted at different time points. The 110-kb Stat5 locus in the mouse was bracketed with loxP sites, and its deletion was accomplished by using two Cre-expressing transgenic lines. Loss of Stat5 prior to pregnancy prevented epithelial proliferation and differentiation. Deletion of Stat5 during pregnancy, after mammary epithelium had entered Stat5-mediated differentiation, resulted in premature cell death, indicating that at this stage epithelial cell proliferation, differentiation, and survival require Stat5.

Citing Articles

Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.

Van Keymeulen A Adv Exp Med Biol. 2025; 1464():167-184.

PMID: 39821026 DOI: 10.1007/978-3-031-70875-6_10.


STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs.

Lee H, Chen J, Philips R, Lee S, Feng X, Wu Z bioRxiv. 2025; .

PMID: 39803507 PMC: 11722272. DOI: 10.1101/2024.12.20.629685.


Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition.

Williams M, Wang X, Bastos H, Grondys-Kotarba G, Wu Q, Jin S Blood Adv. 2024; 9(2):291-309.

PMID: 39374575 PMC: 7617191. DOI: 10.1182/bloodadvances.2024014046.


Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T cell proliferation.

Lin J, Ge M, Liu C, Holewinski R, Andresson T, Yu Z Nat Commun. 2024; 15(1):7372.

PMID: 39191751 PMC: 11349758. DOI: 10.1038/s41467-024-50925-6.


STAT5B SH2 variants disrupt mammary enhancers and the stability of genetic programs during pregnancy.

Lee H, Liu C, Hennighausen L bioRxiv. 2024; .

PMID: 38903072 PMC: 11188103. DOI: 10.1101/2024.05.06.592736.


References
1.
Liu X, Robinson G, Hennighausen L . Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol. 1996; 10(12):1496-506. DOI: 10.1210/mend.10.12.8961260. View

2.
Moriggl R, Topham D, Teglund S, Sexl V, Mckay C, Wang D . Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 1999; 10(2):249-59. DOI: 10.1016/s1074-7613(00)80025-4. View

3.
Wen X, Lin H, Shih H, Kung H, Ann D . Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells. J Biol Chem. 1999; 274(53):38204-10. DOI: 10.1074/jbc.274.53.38204. View

4.
Lord J, McIntosh B, Greenberg P, Nelson B . The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol. 2000; 164(5):2533-41. DOI: 10.4049/jimmunol.164.5.2533. View

5.
Seagroves T, Lydon J, Hovey R, Vonderhaar B, Rosen J . C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol. 2000; 14(3):359-68. DOI: 10.1210/mend.14.3.0434. View